SCHEMBL7672569

SCHEMBL7672569

O=C(Nc1ccccc1O)c1cccc2ccccc12

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 P62805 1/20 0.69
EP300 Q09472 1/20 0.69
PRMT1 Q99873 1/20 0.69
NPC1 O15118 3/20 0.69
GAA P10253 2/20 0.69
LMNA P02545 1/20 0.69
TP53 P04637 1/20 0.69
HTT P42858 1/20 0.69
MAPT P10636 2/20 0.62
GFER P55789 1/20 0.62
KDM4E B2RXH2 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
DEGS1 O15121 1/20 0.62
RAB9A P51151 3/20 0.60
METAP2 P50579 1/20 0.59
MMP3 P08254 1/20 0.59
HDAC8 Q9BY41 1/20 0.59
ALDH1A1 P00352 1/20 0.58
CHRNB2 P17787 1/20 0.57
CHRNB4 P30926 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9678353 0.90 H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 (0.62) H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16EP300PRMT1NPC1GAA
SCHEMBL21275460 0.88 RAB9A (0.76) H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16EP300PRMT1NPC1GAA
SCHEMBL331600 0.87 NPC1 (0.69) H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16EP300PRMT1NPC1GAA
SCHEMBL12368193 0.84 MEN1 (0.66) NPC1GAALMNATP53HTT
SCHEMBL9281809 0.83 GFER (0.76) NPC1GAALMNAMAPTGFER
SCHEMBL14413353 0.82 H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 (1.00) H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16EP300PRMT1NPC1GAA
SCHEMBL845142 0.82 LMNA (1.00) NPC1GAALMNATP53HTT
SCHEMBL21446829 0.82 KDM4E (0.72) H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16EP300PRMT1NPC1GAA
SCHEMBL3182095 0.82 ALDH1A1 (0.67) H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16EP300PRMT1NPC1GAA
SCHEMBL27491350 0.82 CYP1A2 (0.70) H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16EP300PRMT1NPC1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020151720-A1 NAPHTHOL DERIVATIVES KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) 2002-10-17 US disclosed
EP-0421293-B1 Aqueous preparations of C.I. azoic diazo components their manufacture and their use HOECHST AG (DE) 1996-08-28 EP disclosed
EP-0372536-B1 ONE-PHASE PROCESS FOR PRODUCING PRINTS USING REACTIVE DYES BESIDES AZOIC DEVELOPING DYES ON ALKALI-PRE-IMPREGNATED TEXTILES HOECHST AKTIENGESELLSCHAFT (DE) 1993-06-09 EP disclosed
US-5104416-A Textile printing pastes; simplified preparation HOECHT AKTIENGESELLSCHAFT (DE) 1992-04-14 US disclosed
EP-0421293-A2 Aqueous preparations of C.I. azoic diazo components their manufacture and their use HOECHST AKTIENGESELLSCHAFT (DE) 1991-04-10 EP disclosed
EP-0372536-A2 One-phase process for producing prints using reactive dyes besides azoic developing dyes on alkali-pre-impregnated textiles HOECHST AKTIENGESELLSCHAFT (DE) 1990-06-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020151720-A1 NAPHTHOL DERIVATIVES NAP1L1, IK, NAP1L4 H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 1294/4885EP300 2079/4885PRMT1 1379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.